Citation: P. Smith et al., Modulating effect of estrogen and testosterone on prostatic stromal cell phenotype differentiation induced by noradrenaline and doxazosin, PROSTATE, 44(2), 2000, pp. 111-117
Authors:
Kassen, AE
Sensibar, JA
Sintich, SM
Pruden, SJ
Kozlowski, JM
Lee, C
Citation: Ae. Kassen et al., Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: Role of heparin/heparan-degrading enzymes, PROSTATE, 44(2), 2000, pp. 124-132
Authors:
Rubio, N
Villacampa, MM
El Hilali, N
Blanco, J
Citation: N. Rubio et al., Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker, PROSTATE, 44(2), 2000, pp. 133-143
Authors:
Oberley, TD
Zhong, WX
Szweda, LI
Oberley, LW
Citation: Td. Oberley et al., Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium, PROSTATE, 44(2), 2000, pp. 144-155
Authors:
Schwab, TS
Stewart, T
Lehr, J
Pienta, KJ
Rhim, JS
Macoska, JA
Citation: Ts. Schwab et al., Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures, PROSTATE, 44(2), 2000, pp. 164-171
Authors:
Plonowski, A
Schally, AV
Varga, JL
Rekasi, Z
Hebert, F
Halmos, G
Groot, K
Citation: A. Plonowski et al., Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways, PROSTATE, 44(2), 2000, pp. 172-180
Authors:
Harris, MT
Feldberg, RS
Lau, KM
Lazarus, NH
Cochrane, DE
Citation: Mt. Harris et al., Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate, PROSTATE, 44(1), 2000, pp. 19-25
Citation: Cj. Johansson et Po. Gunnarsson, Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer, PROSTATE, 44(1), 2000, pp. 26-30
Citation: W. Xie et al., Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat, PROSTATE, 44(1), 2000, pp. 31-39
Authors:
Mahapokai, W
Xue, Y
van Garderen, E
van Sluijs, FJ
Mol, JA
Schalken, JA
Citation: W. Mahapokai et al., Cell kinetics and differentiation after hormonal-induced prostatic hyperplasia in the dog, PROSTATE, 44(1), 2000, pp. 40-48
Citation: S. Ponniah et al., PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome, PROSTATE, 44(1), 2000, pp. 49-54
Citation: Sp. Fraser et al., Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of strongly and weakly metastatic cell lines, PROSTATE, 44(1), 2000, pp. 61-76
Citation: G. Pirtskhalaishvili et Jb. Nelson, Endothelium-derived factors as paracrine mediators of prostate cancer progression, PROSTATE, 44(1), 2000, pp. 77-87
Authors:
Thompson, TC
Timme, TL
Park, SH
Yang, G
Ren, CZ
Citation: Tc. Thompson et al., Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease, PROSTATE, 43(4), 2000, pp. 248-254
Authors:
Johnson, MA
Hernandez, I
Wei, YL
Greenberg, N
Citation: Ma. Johnson et al., Isolation and characterization of mouse probasin: An androgen-regulated protein specifically expressed in the differentiated prostate, PROSTATE, 43(4), 2000, pp. 255-262
Authors:
Zhang, XJ
Lee, C
Ng, PY
Rubin, M
Shabsigh, A
Buttyan, R
Citation: Xj. Zhang et al., Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein, PROSTATE, 43(4), 2000, pp. 278-285